Stoke Therapeutics Inc. (STOK)
NASDAQ · Healthcare
Stoke Therapeutics Inc. Cash on Hand 2022–2025
Stoke Therapeutics Inc. annual/quarterly cash on hand history from 2022 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Stoke Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 84.2M, a 34.19% decrease year-over-year.
- Stoke Therapeutics Inc. cash on hand for 2025 were 84.2M, a 34.19% decrease from 2024.
- Stoke Therapeutics Inc. cash on hand for 2024 were 128.0M, a 33.15% decrease from 2023.
- Stoke Therapeutics Inc. cash on hand for 2023 were 191.4M, a 68.59% increase from 2022.
- Stoke Therapeutics Inc. cash on hand for 2022 were 113.6M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Stoke Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $84 |
| 2024 | $128 |
| 2023 | $191 |
| 2022 | $114 |
| Stoke Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $84 |
| 2024-12-31 | $128 |
| 2023-12-31 | $191 |
| 2022-12-31 | $114 |
Stoke Therapeutics Inc. Cash on Hand — FAQ
Stoke Therapeutics Inc. (STOK) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see STOK's cash on hand history?
The chart and table above show Stoke Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.